First Wave BioPharma, Inc. (FWBI)
NASDAQ: FWBI · IEX Real-Time Price · USD
2.740
+0.010 (0.37%)
At close: Apr 26, 2024, 4:00 PM
2.820
+0.080 (2.92%)
After-hours: Apr 26, 2024, 5:37 PM EDT

First Wave BioPharma Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Year 2023202220212020201920182017201620152014
Net Income
-16.1-14.97-84.52-41.73-15.18-13.53-11.1-14.59-5.93-2.37
Depreciation & Amortization
0.030.030.540.561.020.80.750.730.730.43
Share-Based Compensation
1.130.971.370.551.182.481.10.600
Other Operating Activities
2.25-8.7124.3420.34-1.06-0.612.068.721.030.93
Operating Cash Flow
-12.38-22.34-32.29-11.22-14.03-10.87-7.18-4.53-4.17-1.01
Capital Expenditures
00-0.070.09-0.02-0.06-0.03-0.01-0.02-0.19
Acquisitions
00000-0.25000-0.56
Other Investing Activities
-0.5--10.25-------
Investing Cash Flow
-0.50-10.320.09-0.02-0.31-0.03-0.01-0.02-0.75
Share Issuance / Repurchase
15.8323.0537.570.999.4811.95.015.2800.86
Debt Issued / Paid
-0.6-0.640.092.863.61-0.1911.895.020.99
Other Financing Activities
0-6.677.1113.20.06---1.42-0.34-
Financing Cash Flow
15.2315.7444.7617.0513.1411.716.015.754.681.85
Exchange Rate Effect
0-0.260.03-0.03-0.0300-0.0100
Net Cash Flow
2.35-6.62.165.91-0.910.54-1.21.20.490.09
Free Cash Flow
-12.38-22.34-32.36-11.13-14.06-10.92-7.22-4.55-4.19-1.2
Free Cash Flow Per Share
-36.80-622.19-15226.08-16445.22-26328.25-29719.32-28517.60-29360.73-48572.05-14201.09
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).